Cecil Textbook of Medicine, I. Wyngaarden JB, Smith LH, BennettJC, eds. 19th ed. Philadelphia, PA: WB Saunders; 1992 ;145:948.
2.
Skullerud K. , Halvorsen K.Encephalomyelopathy following intrathecal methotrexate treatment in a child with acute leukemia. Cancer . 1978 ;5:1211-1215.
Bleyer WA, Drake JC, Chabner BANeurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia. N Engl J Med.1973;289:770-773.
5.
Hahn AF, Feasby TE, Gilbert JJParaparesis following intrathecal chemotherapy. Neurology . 1983;33:1032-1038.
6.
Werner RAParaplegia and quadriplegia after intrathecal chemotherapy. Arch Phys Med Rehabil.1988;69:1054-1056.
7.
Dunton SF, Nitschke R., Spruce WE, et al. Progressive ascending paralysis following administration of intrathecal and intravenous cytosine arabinoside: a pediatric oncology group study. Cancer. 1986;57:1083-1088.
8.
von der Weid NX, de Crousaz H., Beck D., et al. Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia. Med Pediatr Oncol.1991;19: 192-198.
Saleh MN, Christian ES, Diamond BRIntrathecal cytosine arabinoside-induced acute, rapidly reversible paralysis . Am J Med.1989;86(6 pt. 1):729-730.
11.
Gagliano RG , Costanzi JJParaplegia following intrathecal methotrexate: report of a case and review of the literature. Cancer. 1976;37:1663-1668.
12.
Ochs J., Rivera G., Aur RJCentral nervous system morbidity following an initial isolated central nervous system relapse and its subsequent therapy in childhood acute lymphoblastic leukemia. J Clin Oncol.1985;3:622-626.
13.
Geiser CF, Bishop Y., Jaffe N.Adverse effects of intrathecal methotrexate in children with leukemia in remission . Blood. 1975;45:189-195.
14.
Duttera MJ, Bleyer WA, Pomeroy TCIrradiation, methotrexate toxicity and the treatment of meningeal leukemia . Lancet. 1973;2:703-707.
15.
Dunkelman H. , Earl HM, Twelves C.Acute reversible neurological deficit following intrathecal chemotherapy. Cancer Chem Pharm.1989;27:329-330.
16.
Cohen JJ, Stark B., Kaplinsky L., et al. Methotrexate-induced leukoencephalopathy is treatable with high-dose folinic acid: a case report and analysis of the literature. Pediatr Hematol Oncol.1990;7:79-87.
17.
Price RATherapy related central nervous system diseases in children with acute lymphocytic leukemia. In: Mastrangelo R, Poplack DG, Riccardi R, eds. Central Nervous System Leukemia — Prevention and Treatment . Boston, MA: Martinus Nijhoff ; 1983:ii:13-14.